Wednesday, August 12, 2009
American Pain Society asks FDA to Modify Restricted Distribution of Onsolis
In an open letter to the U.S. Food and Drug Administration, the American Pain Society has asked that the restricted distribution for Onsolis, a product that releases fentanyl for absorption through oral mucous membranes, be modified on behalf of terminally ill patients.
<< Back to Article Listings
If you wish to speak with a
Hospice Pharmacia Pharmacist or
Certified Technician, please call 877.882.7820.
Copyright ©, excelleRx Inc. 2010.
All Rights Reserved. No part of this work may be reproduced in any means
without the written permission of excelleRx Inc.
